Content created by Office of Budget (OB)
Fiscal Year 2021
Released March, 2020
Topics on this page: HHS FY 2021 Annual Performance Plan and Report Summary of Changes in Performance Measures Table
HHS FY 2021 Annual Performance Plan and Report Summary of Changes in Performance Measures Table
| Division | Unique Identifier | Change Type | Change | Reason for Change |
|---|---|---|---|---|
| ASA | 2.6 | Revised result | Revised FY 2018 result from 73 percent to 72.8 percent Revised FY 2019 Target from 75 percent to 73 percent Revised FY 2019 Result from 74 percent to 73.5 percent Revised the date that data will become available for FY 2021 from 12/30/21 to 9/30/21 |
Revised information to align with the information reported in the Management Priorities section of the FY 2021 HHS Annual Performance Plan and Report. |
| ASPR | 2.4.13a | Increase the number of new licensed medical countermeasures within BARDA | Revised performance goal title to Increase the number of new licensed medical countermeasures across Biomedical Advanced Research and Development Authority (BARDA) programs | Clarified what data HHS reports for this performance goal. This performance goal reports data across all BARDA programs. |
| CDC | 3.2.5 | Discontinued performance goal | Removed performance goal from FY 2021 HHS Annual Performance Plan and Report | Discontinued performance goal due to achieving the performance target and efforts to align antibiotic resistance goals with the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria. |
| CDC | 7.2.6 | Discontinued performance goal | Removed performance goal from FY 2021 HHS Annual Performance Plan and Report | Discontinued this performance goal in FY 2017. However, HHS continued to report on this program's progress in the language of the Annual Performance Plan and Report. HHS plans to replace this measure with two new measures in FY 2021 to monitor overdose death data for discrete types of opioids to better guide prevention activities. |
| CMS | MCR30 | Discontinued performance goal | Replaced a current performance goal for Shift Medicare Health Care Payments from Volume to Value | Replaced MCR30 with another performance goal (MCR36) that focuses on testing Alternative Payment Models (APMs) that include downside risk as an incentive for clinicians to deliver better care at a lower cost and reward quality and efficiency of care. |
| CMS | MCR31 | Discontinued performance goal | Discontinued the Improve Patient and Family Engagement by Improving Shared Decision-Making performance goal | Discontinued performance goal due to recent and future changes to the Consumer Assessment of Healthcare Providers survey which prevent HHS from using it as an effective source for reporting progress for this performance goal. |
| CMS | MCR36 | Changed methodology | Changed the methodology for a Shift Medicare Health Care Payments from Volume to Value performance goal | Revised performance goal for consistency with the Secretary's goals to accelerate the percentage of U.S. health care payments tied to quality and value through the adoption of downside risk APMs. Changed reporting cycle changed from fiscal year to calendar year to reflect the data collection cycle. |
| CMS | MCR36 | Revised performance goal title | Revised performance goal title to Increase the percentage of Medicare health care dollars tied to Alternate Payment Models incorporating downside risk | Revised title to more accurately reflect the performance goal. |
| CMS | QIO7.2 | Discontinued performance goal | Replaced QIO 7.2: Demonstrate improvement in nursing home health care quality by reducing the number of one-star nursing homes with a new performance goal | Replaced QIO 7.2 with a new measure due to the change in the methodology for the Nursing Home Five Star Quality Rating System. HHS will develop a new baseline and future targets for QIO 7.3 next year. |
| CMS | QIO7.3 | Added a new performance goal | Added QIO 7.3: Demonstrate improvement in nursing home health care quality by reducing the number of one-star nursing homes as a developmental measure | Replaced QIO 7.2 with QIO 7.3. Changes to the Nursing Home Five Star Quality Rating System made the data invalid for HHS reporting purposes. HHS will develop a new baseline and future targets for QIO 7.3 next year. |
| CMS | QIO11 | Changed methodology | Changed methodology to reflect an annual reduction | Will revise targets to reflect a 2 percent annual reduction after HHS sets a new baseline for 2019-2024. |
| CMS | QIO11 | Revised result availability date | Revised CY 2018-CY 2021 result availability date | Revised CY 2018- CY 2021 result availability date from December 31 to January 31. |
| IHS | MH-1 | Revised FY 2020 target | Revised FY 2020 target from 14,900 to 21,860 tele-behavioral health encounters nationally among American Indians and Alaska Natives | Increased FY 2020 target based on recent results. In FY 2019, the result is 17,933 tele-behavioral health encounters which exceeds the original FY 2020 target of 14,900. |